Transchem Ltd

Price story A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Transchem Ltd is in stage 2. The phase helps read everything below.

Transchem Ltd's share price was ₹415 at the close on 16 October 2026. It has been rising for 60 weeks. That is 52.6% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹319 and ₹415, and today it sits 99% of the way up from that low.

There is not enough history yet to compare it with the NIFTY 500.

Over the last 2 months the share price moved +30% while the NIFTY 500 moved −6%, so it is ahead of the index over that whole period. The chart below shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Valuation P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

Transchem Ltd's P/E is 75.5×, near the high end of its own history: higher than 80% of past readings. Its usual P/E (the middle reading) is 19.6×, over 10.0 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Business trend Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Transchem Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 9 quarters of 2 measures, with some gaps.

Why it matters: with too little history, we say so rather than guess a direction.

One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.

The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

4-Factor Sector Score

50.5 out of 100, rank 14 of 63 in Trading, with 52% of the evidence available.

Transchem Ltd scores 50.5 out of 100 against the 63 companies it is compared with in Trading, ranking 14. Some evidence is missing, so the score is pulled toward the middle on purpose.

The four parts add up to the total exactly: 18.6 + 10.4 + 9.3 + 12.2 = 50.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Revenue Revenue is everything the company billed its customers in the period.

Transchem Ltd reported ₹0.0 Cr of revenue in the Jun 26 quarter. The last full year, FY26, came in at ₹0.0 Cr. The last four reported quarters add to ₹0.0 Cr. A growth rate over several years is not shown, because there are too few years of figures to work one out properly.

FY26 revenue was ₹0.0 Cr, −100.0% on the year before.

Is growth speeding up? Revenue over the last 12 months grew −100.0%, against −100.0% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +47.7%, against +15.7% a year (accelerating).

Operating margin Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

We do not have a clean operating margin for Transchem Ltd. Its accounts do not report the operating-profit line this section uses, which is common for lenders and holding companies. The other sections show what its filings do report.

Why: the operating margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason.

Net profit Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

Transchem Ltd earned ₹3.4 Cr of net profit in the Jun 26 quarter, +245.5% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹4.3 Cr. Over 10 years profit has grown 56.1% a year on average. The same quarter a year earlier earned ₹1.0 Cr.

For the full year, FY26 profit was ₹4.3 Cr (−17.8% on the year before).

Cash flow The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Over the last 3 years Transchem Ltd's operations used more cash than they brought in, so cash conversion was −45%, a gap worth watching. In FY26 its operations used ₹2.9 Cr of cash, against ₹4.3 Cr of profit. After ₹0.0 Cr of spending on assets, free cash was ₹−3.0 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

🚨 Why −45% of profit came in as cash: the cash cycle got 887 days longer between FY21 and FY25, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page.

What to look at next: less of the profit turns into cash than it should, and the cash cycle is 887 days longer. The next section looks at where the cash is stuck.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Transchem Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 376 days in FY25, up from −511 days in FY21. It spent ₹0.0 Cr on assets over the last 3 years. Customers take 376 days to pay, and stock sits for 0 days on average.

Spending on assets: ₹0.0 Cr over the last 3 years. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet.

In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit.

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Transchem Ltd earned a ROCE of 7% in FY26. That is up from a low of −1% in FY18. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 198.9% net margin and 0.03× asset turnover (sales divided by assets).

Why the return is what it is (FY25): a 198.9% net margin × 0.03× asset turnover × 1.01× leverage (assets divided by equity) ≈ 6.0% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed.

Debt Debt-to-equity shows how much of the business is paid for with borrowed money. Interest cover shows how many times operating profit pays the interest bill. Low debt and high cover are the safe combination.

Transchem Ltd had ₹0.0 Cr of borrowings against ₹83.6 Cr of equity in FY26, so its debt is 0.00× its equity. Over 5 years borrowings went from ₹0.0 Cr to ₹0.0 Cr. Over the last 3 of those years it spent ₹0.0 Cr on assets.

The spending on assets is being paid for from cash, not new debt.

Ownership Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Promoters raised their stake in Transchem Ltd by 4.8 percentage points over 8 quarters, the biggest change among its owners. Promoters now own 56.5% of the company. Foreign institutions moved +0.0 points over the same period, to 0.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Why the owners changed: promoters drove it (+4.8 points). They raised their stake step by step.

Balance-sheet safety The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

For Transchem Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

Frequently asked questions